Position in CORT
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$1,249,610
+$170,810 QoQ
Shares Held
31,000
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Intellectus Partners, LLC holds $9,451,424 across 9 Biotechnology names. CORT ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,715 | $2,097,717 | |
| 2 | ABCL |
AbCellera Biologics Inc.
|
546,083 | $1,905,829 | |
| 3 | CORT |
Corcept Therapeutics Inc
This page
|
31,000 | $1,249,610 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
290,417 | $1,245,888 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
53,312 | $1,076,902 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
54,475 | $698,369 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
136,446 | $478,925 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
42,225 | $420,138 |
All Filings in CORT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,249,610 | 31,000 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,078,800 | 31,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,494,858 | 42,051 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,101,223 | 42,251 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,803,065 | 42,051 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $2,512,395 | 49,859 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,538,874 | 54,859 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||